Global Natural Killer Cell Therapy Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Natural Killer Cell Therapy market size will reach 521.41 Million USD in 2025 and is projected to reach 2,296.48 Million USD by 2032, with a CAGR of 23.59% (2025-2032). Notably, the China Natural Killer Cell Therapy market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Natural killer (NK) cell therapy is a form of immunotherapy that utilizes a patient’s own or donor-derived NK cells to treat various diseases, particularly cancer. NK cells are a type of white blood cell that plays a critical role in the body’s innate immune response, specifically targeting and eliminating abnormal or infected cells. In NK cell therapy, these cells are isolated, expanded, and sometimes genetically modified in the lab before being infused back into the patient. The goal is to enhance the activity and effectiveness of NK cells in recognizing and killing cancer cells. NK cell therapy has shown promise in treating several types of cancers, including leukemia, lymphoma, and solid tumors. The therapy can be used alone or in combination with other treatments such as chemotherapy or checkpoint inhibitors. It offers the potential for targeted and personalized cancer treatment with potentially fewer side effects than traditional treatments. Ongoing research and clinical trials are exploring the optimal techniques for producing and administering NK cell therapy to improve patient outcomes and expand its application in the field of cancer immunotherapy.
The major global suppliers of Natural Killer Cell Therapy include Nektar Therapeutics, Innate Pharma, Affimed, Chipscreen Biosciences, Glycostem Therapeutics, Fate Therapeutics, Dragonfly Therapeutics, Nkarta Therapeutics, Kiadis Pharma, NantKwest, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Natural Killer Cell Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Natural Killer Cell Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Natural Killer Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Natural Killer Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Natural Killer Cell Therapy Include:
Nektar Therapeutics
Innate Pharma
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Nkarta Therapeutics
Kiadis Pharma
NantKwest
Natural Killer Cell Therapy Product Segment Include:
NK Cell Therapies
NK Cell Directed Antibodies
Natural Killer Cell Therapy Product Application Include:
Cancer
Gastrointestinal Diseases
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Natural Killer Cell Therapy Industry PESTEL Analysis
Chapter 3: Global Natural Killer Cell Therapy Industry Porter's Five Forces Analysis
Chapter 4: Global Natural Killer Cell Therapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Natural Killer Cell Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Natural Killer Cell Therapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Natural Killer Cell Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Natural Killer Cell Therapy market size will reach 521.41 Million USD in 2025 and is projected to reach 2,296.48 Million USD by 2032, with a CAGR of 23.59% (2025-2032). Notably, the China Natural Killer Cell Therapy market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Natural killer (NK) cell therapy is a form of immunotherapy that utilizes a patient’s own or donor-derived NK cells to treat various diseases, particularly cancer. NK cells are a type of white blood cell that plays a critical role in the body’s innate immune response, specifically targeting and eliminating abnormal or infected cells. In NK cell therapy, these cells are isolated, expanded, and sometimes genetically modified in the lab before being infused back into the patient. The goal is to enhance the activity and effectiveness of NK cells in recognizing and killing cancer cells. NK cell therapy has shown promise in treating several types of cancers, including leukemia, lymphoma, and solid tumors. The therapy can be used alone or in combination with other treatments such as chemotherapy or checkpoint inhibitors. It offers the potential for targeted and personalized cancer treatment with potentially fewer side effects than traditional treatments. Ongoing research and clinical trials are exploring the optimal techniques for producing and administering NK cell therapy to improve patient outcomes and expand its application in the field of cancer immunotherapy.
The major global suppliers of Natural Killer Cell Therapy include Nektar Therapeutics, Innate Pharma, Affimed, Chipscreen Biosciences, Glycostem Therapeutics, Fate Therapeutics, Dragonfly Therapeutics, Nkarta Therapeutics, Kiadis Pharma, NantKwest, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Natural Killer Cell Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Natural Killer Cell Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Natural Killer Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Natural Killer Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Natural Killer Cell Therapy Include:
Nektar Therapeutics
Innate Pharma
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Nkarta Therapeutics
Kiadis Pharma
NantKwest
Natural Killer Cell Therapy Product Segment Include:
NK Cell Therapies
NK Cell Directed Antibodies
Natural Killer Cell Therapy Product Application Include:
Cancer
Gastrointestinal Diseases
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Natural Killer Cell Therapy Industry PESTEL Analysis
Chapter 3: Global Natural Killer Cell Therapy Industry Porter's Five Forces Analysis
Chapter 4: Global Natural Killer Cell Therapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Natural Killer Cell Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Natural Killer Cell Therapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Natural Killer Cell Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Natural Killer Cell Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Natural Killer Cell Therapy Product by Type
- 1.2.1 NK Cell Therapies
- 1.2.2 NK Cell Directed Antibodies
- 1.3 Natural Killer Cell Therapy Product by Application
- 1.3.1 Cancer
- 1.3.2 Gastrointestinal Diseases
- 1.3.3 Others
- 1.4 Global Natural Killer Cell Therapy Market Size Analysis (2020-2032)
- 1.5 Natural Killer Cell Therapy Market Development Status and Trends
- 1.5.1 Natural Killer Cell Therapy Industry Development Status Analysis
- 1.5.2 Natural Killer Cell Therapy Industry Development Trends Analysis
- 2 Natural Killer Cell Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Natural Killer Cell Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Natural Killer Cell Therapy Market Analysis by Country
- 4.1 Global Natural Killer Cell Therapy Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Natural Killer Cell Therapy Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Natural Killer Cell Therapy Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.5 China Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.6 France Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.14 India Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Natural Killer Cell Therapy Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Natural Killer Cell Therapy Market Revenue by Key Suppliers (2021-2025)
- 5.2 Natural Killer Cell Therapy Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Natural Killer Cell Therapy Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Natural Killer Cell Therapy Market Analysis by Type
- 6.1 Global Natural Killer Cell Therapy Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Natural Killer Cell Therapy Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Nektar Therapeutics
- 7.1.1 Nektar Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Nektar Therapeutics Natural Killer Cell Therapy Product Portfolio
- 7.1.3 Nektar Therapeutics Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Innate Pharma
- 7.2.1 Innate Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Innate Pharma Natural Killer Cell Therapy Product Portfolio
- 7.2.3 Innate Pharma Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Affimed
- 7.3.1 Affimed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Affimed Natural Killer Cell Therapy Product Portfolio
- 7.3.3 Affimed Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Chipscreen Biosciences
- 7.4.1 Chipscreen Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Chipscreen Biosciences Natural Killer Cell Therapy Product Portfolio
- 7.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Glycostem Therapeutics
- 7.5.1 Glycostem Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Glycostem Therapeutics Natural Killer Cell Therapy Product Portfolio
- 7.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Fate Therapeutics
- 7.6.1 Fate Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Fate Therapeutics Natural Killer Cell Therapy Product Portfolio
- 7.6.3 Fate Therapeutics Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Dragonfly Therapeutics
- 7.7.1 Dragonfly Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Dragonfly Therapeutics Natural Killer Cell Therapy Product Portfolio
- 7.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Nkarta Therapeutics
- 7.8.1 Nkarta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Nkarta Therapeutics Natural Killer Cell Therapy Product Portfolio
- 7.8.3 Nkarta Therapeutics Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Kiadis Pharma
- 7.9.1 Kiadis Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Kiadis Pharma Natural Killer Cell Therapy Product Portfolio
- 7.9.3 Kiadis Pharma Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 NantKwest
- 7.10.1 NantKwest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 NantKwest Natural Killer Cell Therapy Product Portfolio
- 7.10.3 NantKwest Natural Killer Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Natural Killer Cell Therapy Industry Chain Analysis
- 8.2 Natural Killer Cell Therapy Product Downstream Application Analysis
- 8.2.1 Global Natural Killer Cell Therapy Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Natural Killer Cell Therapy Revenue and Forecast by Application (2020-2032)
- 8.3 Natural Killer Cell Therapy Typical Downstream Customers
- 8.4 Natural Killer Cell Therapy Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
